Published in Cancer on July 15, 2010
Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol (2014) 1.46
Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17
Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11
Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer (2011) 1.09
Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int (2012) 0.99
Cancer-related and treatment-related fatigue. Gynecol Oncol (2014) 0.98
A clinically translatable mouse model for chemotherapy-related fatigue. Comp Med (2013) 0.94
Neurobiological studies of fatigue. Prog Neurobiol (2012) 0.94
A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun (2013) 0.93
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol (2015) 0.85
The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options. Drug Discov Today Dis Models (2011) 0.85
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol (2013) 0.85
Cancer-related fatigue in the elderly. Support Care Cancer (2013) 0.84
Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue. Physiol Behav (2014) 0.81
Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer (2013) 0.81
Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study. Qual Life Res (2013) 0.80
Aiming for a better understanding and management of cancer-related fatigue. Oncologist (2013) 0.80
Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research. J Cancer Sci Ther (2011) 0.78
Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. Support Care Cancer (2015) 0.78
Challenges of advanced hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals. PLoS One (2015) 0.77
Evaluation and management of fatigue in oncology: a multidimensional approach. Indian J Palliat Care (2011) 0.76
Effect of dance on cancer-related fatigue and quality of life. Support Care Cancer (2014) 0.76
Adult Acute Myeloid Leukemia Long-term Survivors. J Leuk (Los Angel) (2014) 0.76
Reality of evidence-based practice in palliative care. Cancer Biol Med (2015) 0.76
Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy. J Clin Psychopharmacol (2016) 0.75
Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development. Support Care Cancer (2014) 0.75
Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle (2016) 0.75
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). Support Care Cancer (2015) 0.75
Modafinil #259. J Palliat Med (2012) 0.75
[Modafinil for the treatment of cancer-related fatigue : an intervention study]. Schmerz (2010) 0.75
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer (1999) 7.87
Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer (2000) 7.25
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst (2008) 2.17
Assessment and management of cancer-related fatigue in adults. Lancet (2003) 2.01
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet (2002) 2.00
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage (1999) 1.89
Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest (2000) 1.86
Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull (2008) 1.82
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology (2000) 1.47
Fatigue associated with cancer and its treatment. Support Care Cancer (2001) 1.38
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32
Management of cancer-related fatigue. Cancer Invest (2005) 1.26
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24
Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract (2000) 1.16
Factor structure of the Profile of Mood States (POMS): two partial replications. J Clin Psychol (1984) 1.12
Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med (2004) 1.10
Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage (2008) 0.99
Assessment of clinical relevant fatigue level in cancer. Support Care Cancer (2007) 0.97
Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology (2002) 0.91
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97
Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer (2011) 3.54
Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03
Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time. Cancer (2012) 2.98
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol (2009) 2.26
Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol (2014) 2.13
Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol (2011) 1.79
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed. BJU Int (2007) 1.72
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial. J Natl Cancer Inst (2010) 1.59
Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst (2009) 1.56
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer (2001) 1.52
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun (2012) 1.48
Cancer-related fatigue and sleep disorders. Oncologist (2007) 1.47
Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol (2013) 1.46
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43
Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40
Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med (2002) 1.39
Fatigue associated with cancer and its treatment. Support Care Cancer (2001) 1.38
Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28
Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer (2004) 1.28
Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28
Management of cancer-related fatigue. Cancer Invest (2005) 1.26
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24
Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008. Am J Public Health (2012) 1.23
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19
Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer (2013) 1.16
Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol (2012) 1.15
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther (2004) 1.14
The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13
Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13
A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13
Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology (2005) 1.13
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer (2013) 1.12
Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer (2011) 1.11
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol (2009) 1.11
Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07
Patients' barriers to receipt of cancer care, and factors associated with needing more assistance from a patient navigator. J Natl Med Assoc (2011) 1.06
IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest (2010) 1.02
Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res (2006) 1.01
The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00
Information-seeking styles among cancer patients before and after treatment by demographics and use of information sources. J Health Commun (2009) 0.99
Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98
Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med (2012) 0.98
Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology (2008) 0.98
Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psychooncology (2011) 0.98
Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group. J Clin Oncol (2008) 0.97
Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat (2004) 0.97
Clinician-patient communication about physical activity in an underserved population. J Am Board Fam Med (2008) 0.97
Geriatric assessment in older patients with breast cancer. J Natl Compr Canc Netw (2009) 0.95
Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. J Clin Oncol (2009) 0.95
Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer (2010) 0.94
The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat (2011) 0.94
Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer (2006) 0.93
Self-reported cancer screening among elderly Medicare beneficiaries: a rural-urban comparison. J Rural Health (2012) 0.93
Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men. Support Care Cancer (2010) 0.93
Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer (2001) 0.92
Pharmacologic treatment of cancer-related fatigue. Oncologist (2007) 0.92